A Study of Ganfort Versus Duotrav in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
This is a single-center, cross-over comparison parallel group randomized trial designed to
evaluate the efficacy and safety of Ganfort compared to Duotrav for a treatment period of 8
weeks each.